https://www.selleckchem.com/pr....oducts/pmsf-phenylme
003). Furthermore, rs907187 was predicted to alter the binding site of E2F1 transcription factor. Specifically, allele G had low binding affinity with E2F1 whose expression positively correlates with PARP1 expression and associated with poor prognosis of patients with NB. By contrast, we did not find genetic association for the SNP rs2048426. These data reveal rs907187 as a novel potential risk variant associated with the failure of induction therapy for high-risk NB. © 2020 Università degli Studi di Napoli Fe
Curtir
Comentario
Compartilhar
